Tag: cardiogenic shock
ACC 2024: Use of Impella CP may boost survival in STEMI patients with cardiogenic shock
Use of the Impella CP (Abiomed) micro-axial flow pump in the treatment of patients with ST-segme...
TCT 2022: TEER in cardiogenic shock patients shows promise for lowering mortality and heart failure hospitalisation
Analysis of data from the Society of Thoracic Surgeons/American College of Cardiology (STS/ACC) ...
Multivessel PCI has similar outcomes to culprit-vessel only PCI for cardiogenic shock patients when mechanical circulatory support used
A new study has found no significant differences in hospital mortality between multivessel percu...
FDA approves extended duration of use for Impella 5.0 and Impella LD heart pumps
Abiomed has announced an expanded US Food and Drug Administration (FDA) approval for the Impella...
Prevalence of multiple organ failure among cardiogenic shock patients has steadily increased
Between 2000 and 2014, in the USA, the percentage of patients with acute myocardial infarction c...
Challenges of conducting a randomised clinical trials to prove the impact of mechanical circulatory support in cardiogenic shock
Mechanical circulatory support is frequently used to stabilise patient haemodynamics in desperate si...
Cardiogenic shock patients would benefit the most from reducing contact-to-balloon time
Data from the FITT-STEMI (Feedback intervention and treatment times in ST-segment elevation myoc...
Haemodynamic support with Impella 2.5 heart pump significantly improves survival when initiated prior to PCI
A study published in the Journal of Interventional Cardiology indicates that the use o...
